These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 18328538

  • 1. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V, Bison E, Ruffatti A, Iliceto S.
    Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538
    [Abstract] [Full Text] [Related]

  • 2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 3. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A, Kickler TS, Petri M.
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [Abstract] [Full Text] [Related]

  • 4. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 5. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG, Cheng HM, Soon SC, Goh E, Chow SK, Yeap SS.
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [Abstract] [Full Text] [Related]

  • 6. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR.
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [Abstract] [Full Text] [Related]

  • 7. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
    Bećarevic M, Andrejević S, Bonaci-Nikolić B, Obradović I, Miljić P, Majkić-Singh N.
    Clin Lab; 2005 Mar; 51(5-6):279-83. PubMed ID: 15991801
    [Abstract] [Full Text] [Related]

  • 8. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P.
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [Abstract] [Full Text] [Related]

  • 9. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [Abstract] [Full Text] [Related]

  • 10. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity.
    Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, Tona F, Iliceto S, Pengo V.
    Thromb Haemost; 2006 Sep; 96(3):337-41. PubMed ID: 16953276
    [Abstract] [Full Text] [Related]

  • 11. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [Abstract] [Full Text] [Related]

  • 12. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
    Hanly JG, Smith SA.
    J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
    [Abstract] [Full Text] [Related]

  • 13. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E, Kobayashi K, Hurley BL, Lopez LR.
    Lupus; 2006 Sep; 15(7):478-83. PubMed ID: 16898186
    [Abstract] [Full Text] [Related]

  • 14. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
    Reshetniak TM, Derksen RV, Alekberova ZS, Horbach D, De Groot F, Nasonov EL, Kalashnikova LA, Match ES, Nasonova VA.
    Klin Med (Mosk); 1998 Sep; 76(3):36-40. PubMed ID: 9575746
    [Abstract] [Full Text] [Related]

  • 15. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Ichikawa K, Tsutsumi A, Atsumi T, Matsuura E, Kobayashi S, Hughes GR, Khamashta MA, Koike T.
    Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
    [Abstract] [Full Text] [Related]

  • 16. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R, Daguzan M, Vandermijnsbrugge F, Gyling M, Cantinieaux B.
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L, Decavele AS, Schouwers S, Devreese K.
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [Abstract] [Full Text] [Related]

  • 18. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 19. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T.
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [Abstract] [Full Text] [Related]

  • 20. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.